Figure 5. miR-145-5p and miR-27b-3p mimic suppress adipogenic differentiation in control cells. Control cell strains (GM05565, GM05757, GM01651) were transfected with 5 nM miR-145-5p or miR-27b-3p mimics on days 0, 3, 6, and 9 during SKP-to-adipocyte differentiation. The treatment groups include 5 nM negative control mimic (NC (M)), 5 nM hsa-miR-145-5p mimic (145 (M)) and 5 nM hsa-miR-27b-3p mimic (27b (M)); qPCR analysis was performed for miR-145-5p (A), and miR-27b-3p (B) both normalized to U6 as well as for IRS1 (C), KLF4 (D), KLF5 (E), PHB (F), PPARγ (G) and LPL (H) all normalized to GAPDH. (I) Bodipy staining (green) of lipid droplets on day 12 of differentiation with representative images (40x magnification; scale bar: 20 μm). DAPI was used as a counterstain. (J) Quantification of the percentage of the Bodipy-positive area normalized to the DAPI area. (K) Quantification of the percentage of Bodipy-positive cells normalized to the total number of DAPI-positive cells. (A–H) Values are presented as the mean ± SD (n=3); p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; two-way ANOVA with Tukey’s multiple comparison test. (J, K) Values are presented as the mean ± SD (n=3); p > 0.05; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; Ordinary one-way ANOVA with Dunnett’s multiple comparison test.